Drugs To Watch: Potential Blockbusters Of 2014

PHILADELPHIA, April 16, 2014 /PRNewswire/ -- The Intellectual Property & Science business of Thomson Reuters , the world's leading provider of intelligent information for businesses and professionals, released its annual forecast of the leading drugs to watch in 2014, including three potential blockbuster treatments anticipated to attain more than $1 billion in sales through 2019, after entering the marketplace this year.

Hey, check out all the research scientist jobs. Post your resume today!